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Copper is a ubiquitously essential nutrient for cells. In this issue of Cell Metabolism, Kim et al. (2010) demon-
strate that tissue copper status can be communicated across organ systems. In a mouse model for cardiac
copper deficiency, a serum-carried signal mobilized liver and intestinal copper by inducing ATP7A, a copper-
exporting ATPase.Copper is an essential nutritional trace
element that is widely employed as a
cofactor for enzymes acting in oxygen
chemistry and electron transfer. Although
less abundant in cells than other essential
metals such as iron and zinc, copper
is broadly used in reactions that span
the functions of respiration, antioxidant
defense, pigment and connective tissue
formation, neurotransmitter synthesis,
and iron oxidation. In mammals, the
manifestations of copper deficiency are
numerous and range from neurological
and hematological disorders to connec-
tive tissue deficits (Madsen and Gitlin,
2007; Tao and Gitlin, 2003). Given the bio-
logical importance of copper, intense
research has focused on the molecular
pathways for copper metabolism. This
has identified cell-surface and intracel-
lular copper transporters, as well as
soluble copper chaperones that ferry the
metal to key destinations in the cell (Barry
et al., 2010; Kaplan and Lutsenko, 2009;
Robinson and Winge, 2010). A great
deal, therefore, is known about copper
homeostasis at the single-cell level. Yet
in multicellular species, control of copper
metabolism must extend beyond the cell
and cross multiple organ systems.
In mammals, the bulk of dietary copper
absorbed by the intestine rapidly enters
the liver, where the metal is then elimi-
nated through the bile. Only a fraction of
dietary copper enters the circulation for
distribution to peripheral organs (Madsen
and Gitlin, 2007; Tao and Gitlin, 2003).
Except in extreme cases of genetic disor-
ders of copper transport (e.g., Wilson’s
and Menkes diseases, described below),
copper homeostasis operates to near
perfection. Irrespective of large fluctua-
tions in dietary copper, the metal is
adequately delivered to peripheral organsand properly eliminated to prevent toxicity
from copper overload (Kaplan and Lut-
senko, 2009; Madsen and Gitlin, 2007;
Tao and Gitlin, 2003). Such elegant ho-
meostasis of the metal is sure to involve
cross-organ communication, but to date
direct evidence for systemic copper sig-
naling has been lacking.
Work in this issue (Kim et al., 2010)
now provides evidence for a systemic
signaling mechanism to control copper
metabolism. This somewhat serendipi-
tous finding originated in the study of
a mouse model for cardiac copper defi-
ciency. The Ctr1hrt/hrt mouse specifically
lacks, in cardiac tissue, the Ctr1 high-
affinity copper transporter. This mouse
with low cardiac copper presented with
the anticipated severe dilated cardiomy-
opathy. However, as a surprising out-
come, the mice also exhibited a striking
decline in liver levels of copper and a
concomitant rise in serum copper. Evi-
dently, the animals responded to cardiac
copper deficiency by elevating circulatory
copper at the expense of liver copper
stores (Figure 1).
Studies of the underlying mechanism
pointed to changes in expression of the
Cu efflux pump, ATP7A. In the gastroin-
testinal tract, this copper-transporting
ATPase normally functions to transfer
copper across the basolateral membrane
of intestinal epithelial cells, thus ensuring
the delivery of dietary copper into the
portal circulation. Adult liver does not nor-
mally express ATP7A to any significant
degreebut instead expresses the homolo-
gous ATP7BCu transporter that facilitates
copper export into the bile (Barry et al.,
2010; Kaplan and Lutsenko, 2009; Mad-
sen and Gitlin, 2007; Tao and Gitlin,
2003). Fine-tuned expression of ATP7A
andATP7B is essential for copper homeo-Cell Metabolisstasis. Inherited mutations in ATP7A
lead to a fatal disorder of copper defi-
ciency (Menkes disease), and ATP7B
mutations cause a familial copper over-
load syndrome of the liver (Wilson’s
disease) (Barry et al., 2010; Kaplan and
Lutsenko, 2009; Madsen and Gitlin,
2007; Tao and Gitlin, 2003). Although the
ATP7A gene appears silent in normal liver,
the Ctr1hrt/hrt mouse in the present study
by Kim et al. exhibited a striking increase
in expression of liver ATP7A, and the
transporter was also induced in the intes-
tine (Kim et al., 2010). Evidently, copper
deficiency in the heart signaled an adap-
tive stress response to mobilize copper
from the liver and intestine via the action
of ATP7A. Prior to this study, liver was
not known as a storage organ for copper,
only as a vehicle for eliminating copper
through the bile. The induction of liver
ATP7A with cardiac copper deficiency
unveiled a new pool of liver copper that
is capable of being mobilized. Even more
strikingwas the evidence that such activa-
tion of liver ATP7A involved a certain
soluble serum factor. Indeed, serum from
the Ctr1hrt/hrt mouse was seen to induce
ATP7A expression in cells in culture (Kim
et al., 2010).
A previous precedent for systemic
metal signaling is the iron-responsive
peptide hormone hepcidin. Iron overload,
inflammatory conditions, and theunfolded
protein response all signal the liver to
produce and release hepcidin into circula-
tion. Serum hepcidin then targets intes-
tinal and macrophage cells, where it acts
to block iron release from the iron export
protein ferroportin (De Domenico and
Kaplan, 2009; Ganz, 2008). Based on the
current report by Kim et al. (2010), we
now know that cross-organ communica-
tion of metal status is not unique to iron.m 11, May 5, 2010 ª2010 Elsevier Inc. 343
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Figure 1. Systemic Signaling of Cardiac Copper Status
In Ctr1hrt/hrt mice, cardiac copper deficiency signals a stress response to mobilize copper stores from the
intestine and liver. A response factor (blue pentagons) is proposed to be released from the heart into circu-
lation where it can target receptors (light blue) on the liver and intestine. Activation of these receptors
signals the induction of the ATP7A gene (dotted arrow) encoding the Cu-transporting ATPase (orange
box) that acts to export tissue copper (green dots) into circulation. Artwork assistance is by Kate Mahan.
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PreviewsTissue copper status can likewise be
sensed and signaled to organs at a
distance via a specific serum-response
factor.
The findings by Kim et al. (2010) will
undoubtedly foster new directions for
studies of copper metabolism. For exam-
ple, what is the signaling molecule?344 Cell Metabolism 11, May 5, 2010 ª2010Perhaps this represents a new peptide
hormone that targets a liver- and intes-
tinal-specific receptor for controlling
ATP7A expression (Figure 1). And is this
signal specific for cardiac copper defi-
ciency? The heart has a particularly high
demand for copper throughmitochondrial
respiration, but the same can be said forElsevier Inc.neurological and muscle tissue. It is
conceivable that deficits in copper from
a variety of organs will elicit an ‘‘SOS’’
response tomobilize copper stores. Addi-
tionally worth pursuing is the newly re-
vealed storage pool of copper in the liver.
In what form is the copper stored? Is it
sequestered in secretory vesicles or
bound to proteins such as metallothio-
nein? Lastly, now that systemic signals
are evident for both copper and iron, will
the same hold true for other inorganic
nutrients such as zinc and manganese?
The potential toxicity of these essential
heavy metals would seem to justify a
cross-organ signaling system of control.
Future studies are likely to reveal a host
of serum-response factors that serve
to communicate tissue metal status and
facilitate proper adaptive responses.REFERENCES
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